Microbial transformation of danazol with Cunninghamella blakesleeana and anti-cancer activity of danazol and its transformed products
article
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
Cunninghamella blakesleeana transformed danazol into new metabolites, some of which exhibited anti-cancer activity.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Biotransformation of danazol (1) (17β-hydroxy-17α-pregna-2,4-dien-20-yno-[2,3-d]-isoxazole) with Cunninghamella blakesleeana yielded three new metabolites 2-4 and a known metabolite 5. These metabolites were identified as 14β,17β-dihydroxy-2-(hydroxymethyl)-17α-pregn-4-en-20-yn-3-one (2), 1α,17β-dihydroxy-17α-pregna-2,4-dien-20-yno-[2,3-d]-isoxazole (3), 6β,17β-dihydroxy-17α-pregna-2,4-dien-20-yno-[2,3-d]-isoxazole (4), and 17β-hydroxy-2-(hydroxymethyl)-17α-pregn-1,4-dien-20-yn-3-one (5). Danazol (1) and its derivatives were evaluated against cervical cancer cell line (HeLa). Compound 1 showed a potent cytotoxicity with IC50=0.283±0.013 μM, as compared to doxorubicin (IC50=0.506±0.015 μM), where compound 3 was also found to be significantly active with IC50=13.427±0.819 μM.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (29)
- Biotransformation of danazol by Fusarium solani and Gibberella fujikuorii, and prolyl endopeptidase inhibition studies of transformed products via openalex
- Evaluation of the true precocious puberty rats induced by neonatal administration of Danazol: Therapeutic effects of nourishing "Yin"- removing "Fire" Chinese herb mixture via openalex
- Microbial Transformation of Danazol via openalex
- Phase II trial of danazol in advanced, recurrent, or persistent endometrial cancer: a Gynecologic Oncology Group study via openalex
- Pituitary Gonadotropin Inhibitory Activity of Danazol via openalex
- The Treatment of Benign Breast Disease with Danazol via openalex
- doi:10.1016/j.steroids.2014.01.001 via openalex
- doi:10.1016/s0015-0282(16)46331-4 via openalex
- doi:10.2174/138527210791616786 via openalex
- W2184353134 via openalex
- W2341620185 via openalex
- W4285719527 via openalex
- W6686513504 via openalex
- W6704458832 via openalex
- doi:10.1080/10242420290018069 via openalex
- doi:10.1248/cpb.54.927 via openalex
- doi:10.1016/j.steroids.2014.06.020 via openalex
- doi:10.1016/j.steroids.2011.06.007 via openalex
- doi:10.1016/j.molcatb.2010.09.001 via openalex
- doi:10.1093/oxfordjournals.annonc.a010717 via openalex
- doi:10.1023/a:1015905832184 via openalex
- doi:10.3109/14756366.2011.590804 via openalex
- doi:10.1002/cbdv.200590019 via openalex
- doi:10.1038/nrc706 via openalex
- doi:10.1046/j.1525-1373.1999.d01-122.x via openalex
- doi:10.1016/j.steroids.2010.05.017 via openalex
- doi:10.1016/j.molcatb.2003.09.012 via openalex
- doi:10.1016/j.tetasy.2009.02.009 via openalex
- doi:10.1016/s0958-1669(00)00142-7 via openalex
Cited by (1)
- Danazol 2022
Source provenance
- openalex
- last seen: 2026-05-11T06:09:19.794676+00:00
- unpaywall
- last seen: 2026-08-05T06:45:03.150373+00:00
License: CC0
· commercial use OK